A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders.
Jan 25, 2024
0
30
Each year, several thousand women in Germany die from ovarian cancer. In many cases, the disease is only detected when it is very advanced and metastases have already formed—usually in the intestines, abdomen or lymph nodes. ...
Jan 24, 2024
0
26
Researchers in the lab of chemist Han Xiao at Rice University have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients.
Jan 24, 2024
0
50
Cancer treatments, including chemotherapy, in addition to killing a large number of tumor cells, also result in the generation of senescent tumor cells (also called "zombie cells"). While senescent cells do not reproduce, ...
Jan 24, 2024
0
53
Inflammation in the gut can trigger a doom loop of sorts. The condition messes with the sensitive relationships between food, digestive acids, microbes and the immune system in ways that can promote further inflammation and, ...
Jan 24, 2024
0
77
Winning on the battlefield takes a combination of precise intelligence and resolute soldiers. But when it comes to the battle against cancer, the immune system's fighters—the T cells—quickly lose their ability to kill ...
Jan 18, 2024
0
23
One of the great promises in the field of cancer immunotherapy is the emergence of cancer vaccines. Unlike traditional vaccines that are tailored to infectious diseases, cancer vaccines work by teaching the immune system ...
Jan 17, 2024
0
2
By taking advantage of mechanisms that allow cancer cells to evade immune attack, UT Southwestern Medical Center researchers have developed a new strategy in animal models that has potential for treating ulcerative colitis. ...
Jan 16, 2024
0
19
A new study has found that patients with non-small cell lung cancer (NSCLC) treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy ...
Jan 16, 2024
0
25
Northwestern Medicine investigators have identified a previously unknown regulator of tumor immune evasion, which may help improve the efficacy of current and future anti-tumor immunotherapies, according to recent findings ...
Jan 15, 2024
0
13
